The effect of rifampin on the replication of MVL51, a bullet-shaped mycoplasmavirus with single-stranded circular DNA of molecular weight 2 x 106, has been examined in a rifampin-resistant host cell. Rifampin does not block the early steps in MVL51 infection but does decrease the total amount of parental viral DNA taken up. The single-stranded parental viral DNA that enters the cell is found in membrane-associated, double-stranded DNA replicative forms I and II. Rifampin had no significant effect on the synthesis of progeny viral DNA RFI and RFII early in infection and SSI (single-stranded progeny viral chromosomes) later in infection. The rifampin block in virus synthesis was found to be in the step converting SSI into assembled virions. Rifampin was shown to affect the synthesis of virus-specific RNA, which suggests that viral transcription is necessary for virion assembly.
MVL51 is a group Li mycoplasmavirus, which are bullet-shaped particles (about 15 by 80 nm) having helical capsid symmetry and containing single-stranded circular DNA of molecular weight 2 x 106 (8, 10) . Viral infection is nonlytic, and infected cells continue to grow and extrude progeny viruses (9) . Replication of MVL51 has been shown to involve three viral DNA intermediates: RFI, covalently closed circular double-stranded DNA; RFII, a nicked form of RFI; and SSI, a circular, singlestranded progeny viral DNA. RFI and RFII are precursors for the synthesis of SSI (6) .
The antibiotic rifampin specifically inhibits initiation of transcription by RNA polymerase. In this paper, we report the effect of rifampin on the synthesis of MVL51 in-a rifampin-resistant host. These data show that virus production is inhibited at concentrations of the antibiotic that have no effect on cell growth. The antibiotic does not inhibit synthesis ofvirus-specific DNAs but inhibits synthesis of some virus-specific RNA required for maturation and/or release.
MATERIALS AND METHODS Cells, viruses, medium, and buffer. Acholeplasma laidlawii JAl was used for virus growth and as the indicator host in these studies. The virus used was MVL51, a group Li mycoplasmavirus described by Liss and Maniloff (9) . Cells and viruses were cultivated in tryptose broth or on tryptose agar plates as described previously (9) . 1 Permanent address: Department of Physics, Calcutta University, Calcutta, India.
The Tris-EDTA-NaCl buffer (pH 8.0) used was 0.01 M Tris, 0.001 M EDTA, 0.1 M NaCl, and Tris-EDTA-NaCl-NaCN buffer was the same buffer containing 10 mM NaCN. The high-salt buffer was Tris-EDTA-NaCl containing 1 M NaCl.
Antibiotics. Rifampin and chloramphenicol were obtained from Sigma Chemical Co. (St. Louis, Mo.). Rifampin solutions were made up in Tris-EDTANaCl buffer 1 day before use and stored at 4 C in the dark.
Preparation of labeled virus. Radioactively labeled MVL51 and viral DNA were prepared as described previously (6) .
Analysis of whole cells. For examination of the effects of antibiotics on the incorporation of radioisotopically labeled compounds in whole cells, logphase cultures of JAl cells were treated with either rifampin or chloramphenicol. After different times 5-ml aliquots were removed, centrifuged, and suspended in 5 Radioactive assay. Gradient fractions were precipitated by adding an equal volume of ice-cold 10% trichloroacetic acid, using bovine serum albumin as carrier. The precipitated samples were filtered, washed, dried, and assayed for radioactivity as previously described (6) .
RNA-DNA hybridization. Pulse-labeled RNA was isolated from uninfected, infected, and infected rifampicin-treated JAl cells by the method described by Mitra (11) . For the infected cell experiment, a log-phase JAl culture was infected with MVL51 at a multiplicity of infection of about 10. Thirty minutes after infection, rifampin (100 /.g/ml) was added to part of the infected culture. Twenty-five minutes later, cells were labeled for 5 min with 40 ACi of [3H]uridine per ml. At the end of the labeling period, cells were rapidly chilled, centrifuged, washed with saline phosphate, and, finally, suspended in 0.05 M sodium acetate (pH 5.0). Sodium dodecyl sulfate (0.5% final concentration) and polyvinyl sulfate (10 ug/ml final concentration) were then added. After 5 min at 4 C, the cell suspensions were extracted twice with phenol saturated with 0.15 M NaCl, 0.015 M sodium citrate (SSC), pH 7.0. The phenol phase was reextracted with 0.05 M sodium acetate (pH 5.0). The aqueous layers were pooled and precipitated with 3 volumes of ethanol at -20 C for 24 h. The nucleic acid precipitate was collected by centrifugation at 4,000 x g for 10 min and resuspended in SSC.
MVL51 replicative form (RF) DNA was isolated from sucrose gradients as previously described (6), dialyzed against SSC, and denatured by heating at 100 C for 10 min and chilling rapidly.
The reaction mixture for hybridization contained 12 ,000 x g for 10 min. The supernatant was decanted, 0.2 volume of 1% protamine sulfate was added, and the mixture was centrifuged at 12,000 x g for 10 min. The precipitate was resuspended in 1 ml of buffer A. For the RNA polymerase assay, 100 ,ul of the resuspended precipitate was used without further purification. The enzyme was assayed by the method of Berg et al. (2), using [3H]uridine as labeled nucleotide and highly polymerized calf thymus DNA (150 ,ug/ml) as template. Potassium phosphate (20 mM) was added to the reaction mixture to inhibit polynucleotide phosphorylase. The enzyme fractions were preincubated for 5 min at room temperature before adding the DNA. The enzyme activity was measured after 10 min of incubation at room temperature and corrected for endogenous DNA by measuring incorporation of
[3H]uridine in the absence of added DNA.
RESULTS
Growth of infected and uninfected cells in the presence of rifampin. During studies of the effect of rifampin on the replication of mycoplasmavirus MVL51 (to be described below), it was observed that the A. laidlawii JAl indicator host, which was used in these and all previous virus studies in this laboratory, was rifampin resistant. The effect of rifampin on the growth of uninfected and MVL51-infected A. laidlawii JAl cells is shown in Fig. 1 . Growth of uninfected cells ( Fig. la) was not affected by low antibiotic concentrations (up to 50 ug/ml).
At 100 ,tg/ml, cell growth continued for 3 h; similar results were found at 200 ,ug/ml. Growth of MVL51-infected cells in the presence of 100 ,ug of rifampin per ml (Fig. lb) was similar to that of infected untreated cells.
Effect of rifampin on cellular RNA and protein synthesis. Incorporation of [3H]uridine in cells treated with 100 Ag of rifampin per ml was not affected for 2 to 3 h after the addition of the drug, after which the incorporation was reduced ( Fig. 2b ). For comparison, in cells treated with 100 ,g of chloramphenicol per ml, uridine incorporation continued at the untreated control cell rate for 1 h and then stopped.
Protein synthesis (Fig. 2a) , as measured by incorporation of labeled amino acids, was barely affected by 100 ,g of rifampicin per ml, whereas it was completely inhibited by 100 ,tg of chloramphenicol per ml.
Effect of rifampin on cellular RNA polymerase. In vitro assays of the RNA polymerase activity in extracts from infected and unin-RIFAMPIN INHIBITION OF MYCOPLASMAVIRUS for this nonlytic virus (Fig. 4) . Rifampin treatment inhibited the growth of the virus, but the extent of inhibition depended upon when during infection the antibiotic was added (Fig. 4a) . The amount of inhibition increased with increasing infection times. For comparison, a parallel experiment was performed with 100 gg of chloramphenicol per ml. Chloramphenicol completely inhibited virus production independent of the time during infection of addition of the drug (Fig. 4b) .
The effect of 2-h treatments of different rifampin concentrations is shown in Fig. 5 infected with MVL51 at a multiplicity of infection of then virus production began at about the same 3. After 5 min, cells were centrifuged to remove un-rate as untreated cells (Fig. 6) . adsorbed viruses and infected cells were resuspended Effect of rifampin on virus-specific RNA in tryptose broth. At different times after infection synthesis. The data presented above show that aliquots were removed and virus assays were per-rifampin inhibits production of virus, although formed, before and after 1-h treatments with either the RNA polymerases from infected and unin-100 Mg of (a) rifampicin or (b) chloramphenicol per fected cells are resistant to the drug. This effect could be due to rifampin only inhibiting the synthesis of virus-specific RNA. To test this possibility, pulse-labeled RNA was isolated from uninfected, MVL51-infected, and infected and rifampin-treated JAl cells and hybridized with MVL51 RF DNA. The results are shown in Table 1 . The amount of RNA hybridized was maximum when RNA from infected cells was used. This amount was reduced 2.5-fold when infected cells were treated with 100 ,ug of rifampicin per ml for 30 min. Hence, rifampin inhibits the synthesis of virus-specific RNA. The activity bound in the filters when RNA from uninfected cells was used may be due to cellular DNA contamination in the RF preparation.
Effect of rifampin on parental RF formation. To examine the effect of rifampin on the early steps in viral replication, JAl cells were either pretreated with the antibiotic before infection or the antibiotic was added along with the virus. Infected cells were then analyzed for the amount of parental viral DNA in subcellular fast (membrane-associated)-and free-sedimenting fractions ( Table 2 ). The total amount of parental viral DNA recovered in the cells (i.e., in the fast-and free-sedimenting .fractions) was reduced when rifampin was added at the start of infection and decreased further by 30-min pretreatment of the cells by rifampin before infection. Longer rifampin pretreatment (up to 60 min) caused no further decrease in recovery of intracellular parental viral DNA (data not shown).
The distribution of parental label shows a marked decrease in the amount of free-sedimenting parental viral DNA relative to fastsedimenting DNA in rifampin-treated infected cells compared to untreated infected cells. Hence, rifampin treatment decreases the amount of uptake of parental viral DNA and shifts the intracellular distribution of the viral DNA, which is incorporated so that it is almost totally recovered in a membrane-associated form. The result of these two effects is that only 60% of the parental viral DNA that can be recovered as fast-sedimenting material in untreated cells is found as fast-sedimenting material in rifampin-treated cells. The free-sedimenting parental viral DNA in rifampintreated cells is reduced to 7% of that found in untreated cells.
To examine the conversion of parental DNA to RF forms, cells were either untreated or treated for 30 min with 100 ug of antibiotic per ml before infection with labeled viruses. Ten minutes after infection, the cells were washed, lysed by Sarkosyl NL97, and sedimented through a 5 to 20% sucrose gradient containing 1 M NaCl, as described in Materials and Methods. The single-stranded DNA of MLV51 was found in double-stranded replicative forms RFI and RFII (Fig. 7a) . This conversion was not affected by pretreating cells for 30 min with 100 ,ug of.rifampin (Fig. 7b) or 100 Mug of chloramphenicol ( Fig. 7c) per ml, indicating that preexisting cell enzyme(s) and cell-specific transcription can perform the initial steps of MVL51 DNA replication.
Effect of rifampin on synthesis of progeny viral DNA. To examine the effect of rifampin on RF replication and single-stranded progeny viral DNA synthesis, infected cells were treated for 30 min with 100 Mg of rifampin per ml at 0 and 90 min after infection. During the last 10 min of antibiotic treatment at each time, [3H]deoxythymidine was added to the culture to label the nascent DNA. A parallel infected culture was not rifampin treated.
It has been shown (6) that, during the first 30 to 40 min of MVL51 infection, RF replication predominates, after which there is a shift to the synthesis of SSI. The synthesis of progeny viral RF molecules in untreated cells and cells treated with rifampin during the first 30 min of infection was similar (Fig. 8a) . Infected cells treated with rifampin during 90 to 120 min after infection made progeny SSI, but no nascent viral DNA could be found in the gradient fraction corresponding to completed virus particles (Fig. 8b) . Lysates of untreated infected cells late in infection show this virus peak, since the lysis procedure used does not disrupt virus particles (6) . The peak must represent viruses in the process of being extruded.
The amount of nascent virus-specific DNA found in the lysates of rifampin-treated cells was greater than in untreated cells (Fig. 8b) .
This difference could account for the amount of cold trichloroacetic acid-precipitable radioactivity in the cell-free supernatant of the untreated VOL. 18, 1976 infected cells. Hence, the difference in amounts of progeny viral DNA between untreated and treated cells in Fig. 8b is due to the release of nascent DNA in progeny viruses from the untreated cells.
To examine whether the single-stranded progeny viral DNA accumulated during rifampin treatment could be assembled into progeny particles upon removal of the drug, part of the rifampin-treated sample (shown in Fig. 8b ) was centrifuged and the cells were resuspended in prewarmed tryptose broth to remove the rifampin. Forty minutes after resuspension, a cell lysate was prepared and sedimented through a high-salt sucrose gradient. It was found (Fig.  8c) that some of the virus-specific DNA synthesized during rifampin treatment could now be recovered at the virus particle position. The total amount of radioactivity in intracellular viral DNA decreased after rifampin removal (cf. Fig. 8b and c) but was recovered as cold trichloroacetic acid-insoluble material in the cell-free supernatant, indicating the release of progeny virus.
DISCUSSION
The indicator host used in these studies, A.
laidlawii JAl, is rifampin resistant, as shown by the inability of rifampin to inhibit cell growth (Fig. la) and RNA and protein synthesis (Fig. 2) . In considerations of whether the rifampin resistance could be due to a permeability barrier, it should be noted that A. laidlawii, like other mycoplasmas, does not have a cell well and is bounded by a single 7-nm lipoprotein cell membrane (4). The observation that virus (but not cell) growth is inhibited by rifampin treatment (Fig. lb and 4) means that the antibiotic must be getting into the cell. The resistance of cellular RNA polymerase activity to rifampin, in an in vitro assay (Fig. 3) , con- firms the whole-cell data.
The results presented here show that rifampin does not block the early steps in MVL51 infection but does decrease the total amount of parental viral DNA taken up by the indicator cells. The single-stranded parental viral DNA that enters the cell is found in membrane-associated, double-stranded DNA RFI and RFII ( Fig. 7 ; Table 2 ). Rifampin had no significant effect on the synthesis of progeny viral DNAs; early in infection this synthesis was mainly in RF molecules and later in infection in SSI DNA ( Fig. 8a and b) . The rifampin block in virus synthesis was seen to be in the step converting SSI (progeny viral chromosomes) into assembled virions. Removal of rifampin allowed these progeny SSI molecules to be packaged and released (Fig. 8c) .
Parenthetically, it was noted that late in infection rifampin treatment led to a larger accumulation of RFII molecules, relative to RFI and SSI, than would be expected at this infection time (Fig. 8b) 
